Arcutis Biotherapeutics Inc (ARQT) Insider Trading
- $26,686,936.21
- $29,251,606.24
- Feb. 4, 2026
- Howard G Welgus
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 4, 2026 | Insider | 9,794 | $25.81 | Sell | $252,783.14 | |
| Feb. 2, 2026 | Insider | 19,833 | $25.50 | Sell | $505,741.50 | |
| Feb. 2, 2026 | Insider | 2,052 | $25.50 | Sell | $52,326.00 | |
| Feb. 2, 2026 | Insider | 3,675 | $25.50 | Sell | $93,712.50 | |
| Feb. 2, 2026 | CFO | 1,320 | $25.50 | Sell | $33,660.00 | |
| Feb. 2, 2026 | Director | 10,000 | $25.05 | Sell | $250,500.00 | |
| Sept. 9, 2025 | Insider | 504 | $17.52 | Sell | $8,830.08 | |
| Sept. 8, 2025 | Insider | 9,625 | $17.54 | Sell | $168,822.50 | |
| Sept. 4, 2025 | Insider | 36,130 | $16.16 | Sell | $583,860.80 | |
| Sept. 2, 2025 | Director | 10,000 | $15.64 | Sell | $156,400.00 | |
| Aug. 21, 2025 | Insider | 2,438 | $15.57 | Sell | $37,959.66 | |
| Aug. 19, 2025 | Insider | 1,750 | $16.16 | Sell | $28,280.00 | |
| Aug. 8, 2025 | Insider | 3,847 | $14.03 | Sell | $53,973.41 | |
| Aug. 4, 2025 | Insider | 11,547 | $14.33 | Sell | $165,468.51 | |
| Aug. 4, 2025 | Insider | 2,622 | $14.33 | Sell | $37,573.26 | |
| Aug. 4, 2025 | CFO | 89 | $14.33 | Sell | $1,275.37 | |
| Aug. 4, 2025 | Insider | 6,330 | $14.33 | Sell | $90,708.90 | |
| Aug. 1, 2025 | Director | 10,000 | $14.30 | Sell | $143,000.00 | |
| July 14, 2025 | Insider | 5,750 | $15.07 | Sell | $86,652.50 | |
| July 10, 2025 | Insider | 23,000 | $15.05 | Sell | $346,150.00 | |
| June 18, 2025 | Director | 10,139 | $13.37 | Sell | $135,558.43 | |
| June 13, 2025 | Director | 2,646 | $13.08 | Buy | $34,609.68 | |
| June 5, 2025 | Director | 378 | $13.41 | Buy | $5,068.98 | |
| June 4, 2025 | Director | 1,890 | $13.32 | Buy | $25,174.80 | |
| May 28, 2025 | Insider | 1,800 | $13.78 | Sell | $24,804.00 | |
| May 21, 2025 | Director | 2,520 | $13.66 | Buy | $34,423.20 | |
| May 19, 2025 | Insider | 7,451 | $14.07 | Sell | $104,835.57 | |
| May 8, 2025 | Insider | 3,871 | $13.59 | Sell | $52,606.89 | |
| May 2, 2025 | Insider | 5,030 | $15.20 | Sell | $76,456.00 | |
| March 24, 2025 | Insider | 1,500 | $17.52 | Sell | $26,280.00 | |
| March 17, 2025 | Insider | 1,200 | $17.61 | Sell | $21,132.00 | |
| March 14, 2025 | Insider | 12,242 | $15.04 | Sell | $184,119.68 | |
| March 3, 2025 | Insider | 2,819 | $13.03 | Sell | $36,731.57 | |
| March 3, 2025 | Director | 10,000 | $13.00 | Sell | $130,000.00 | |
| Feb. 3, 2025 | Insider | 8,338 | $12.70 | Sell | $105,892.60 | |
| Feb. 3, 2025 | Director | 10,000 | $12.71 | Sell | $127,100.00 | |
| Jan. 2, 2025 | Director | 10,000 | $14.67 | Sell | $146,700.00 | |
| Dec. 31, 2024 | Insider | 1,691 | $14.00 | Sell | $23,674.00 | |
| Dec. 20, 2024 | Insider | 15,000 | $15.17 | Sell | $227,550.00 | |
| Dec. 2, 2024 | Director | 10,000 | $12.51 | Sell | $125,100.00 | |
| Nov. 30, 2024 | Insider | 1,093 | $7.11 | Buy | $7,771.23 | |
| Nov. 22, 2024 | Insider | 16,023 | $10.14 | Sell | $162,473.22 | |
| Nov. 19, 2024 | Insider | 1,775 | $9.68 | Sell | $17,182.00 | |
| Nov. 15, 2024 | Insider | 100 | $10.03 | Sell | $1,003.00 | |
| Nov. 11, 2024 | Director | 8,687 | $10.85 | Sell | $94,253.95 | |
| Nov. 4, 2024 | Insider | 5,015 | $8.68 | Sell | $43,530.20 | |
| Nov. 1, 2024 | Director | 10,000 | $8.65 | Sell | $86,500.00 | |
| Oct. 2, 2024 | SVP | 3,725 | $10.01 | Sell | $37,287.25 | |
| Oct. 1, 2024 | Director | 10,000 | $9.26 | Sell | $92,600.00 | |
| Sept. 24, 2024 | CFO | 11,626 | $9.48 | Sell | $110,214.48 |
Insiders are both buying and selling Arcutis Biotherapeutics Inc stock.
The insider traders at Arcutis Biotherapeutics Inc are: Howard G Welgus, Todd Franklin Watanabe, Patrick Burnett, Masaru Matsuda, Bhaskar Chaudhuri, Scott L Burrows, Larry Todd Edwards, John W. Smither, Patricia A Turney, Patrick J Heron, Todd Watanabe, Orbimed Advisors Llc, Latha Vairavan, Life Sciences Viii L Frazier, David W Osborne, Watanabe Todd Franklin, David W. Osborne, Terrie Curran, David Joseph Topper, Jonathan Silverstein, Welgus Howard G., OSBORNE DAVID W, and Howard G. Welgus
The most active insider trader at Arcutis Biotherapeutics Inc is Howard G Welgus with 31 trades.
Orbimed Advisors Llc has sold the most Arcutis Biotherapeutics Inc stock with a total value of $25,610,794.78.
Jonathan Silverstein has bought the most Arcutis Biotherapeutics Inc stock with a total value of $28,659,776.64.
The most recent insider trade for Arcutis Biotherapeutics Inc was on Feb. 4, 2026.
The single biggest insider buy for Arcutis Biotherapeutics Inc was from Jonathan Silverstein with a total value of $14,329,888.32 on Feb. 3, 2020.
The single biggest insider sell for Arcutis Biotherapeutics Inc was from Orbimed Advisors Llc with a total value of $7,287,402.01 on June 24, 2022.
